2026-04-17T12:57:56Zhttps://riubu.ubu.es/oai/requestoai:riubu.ubu.es:10259/100372025-01-25T01:05:28Zcom_10259_6688com_10259_5086com_10259_2604col_10259_6689
Davalos, Veronica
García-Prieto, Carlos A.
Ferrer, Gerardo
Aguilera-Albesa, Sergio
Valencia Ramos, Juan
Rodríguez-Palmero, Agustí
Ruiz, Montserrat
Planas-Serra, Laura
Jordan, Iolanda
Alegría, Iosune
Flores-Pérez, Patricia
Cantarín, Verónica
Fumadó, Victoria
Viadero, Maria Teresa
Rodrigo, Carlos
Méndez-Hernández, Maria
López-Granados, Eduardo
Colobran, Roger
Rivière, Jacques G.
Soler-Palacín, Pere
Pujol, Aurora
Esteller, Manel
2025-01-24T11:49:47Z
2025-01-24T11:49:47Z
2022-08
2589-5370
http://hdl.handle.net/10259/10037
10.1016/J.ECLINM.2022.101515
Most children and adolescents infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain asymptomatic or develop a mild coronavirus disease 2019 (COVID-19) that usually does not require medical intervention. However, a small proportion of pediatric patients develop a severe clinical condition, multisystem inflammatory syndrome in children (MIS-C). The involvement of epigenetics in the control of the immune response and viral activity prompted us to carry out an epigenomic study to uncover target loci regulated by DNA methylation that could be altered upon the appearance of MIS-C.
Unstoppable campaign of Josep Carreras Leukaemia Foundation, Fundacio La Marat o de TV3, Cellex Foundation and CERCA Programme/Generalitat de Catalunya.
application/pdf
eng
Elsevier
eClinicalMedicine. 2022, V. 50, p. 101515
https://doi.org/10.1016/J.ECLINM.2022.101515
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
Multisystem inflammatory syndrome in children
COVID-19
Kawasaki disease
Epigenetics
DNA methylation
Medicina
Medicine
Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective study
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
eClinicalMedicine
50
101515